Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09EHO
|
||||
Former ID |
DNC014662
|
||||
Drug Name |
ABT-751
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 2 | [521967] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H17N3O4S
|
||||
Canonical SMILES |
COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O
|
||||
InChI |
1S/C18H17N3O4S/c1-25-15-8-10-16(11-9-15)26(23,24)21-17-3-2-12-19-18(17)20-13-4-6-14(22)7-5-13/h2-12,21-22H,1H3,(H,19,20)
|
||||
InChIKey |
URCVCIZFVQDVPM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Modulator | [1572591] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.